Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Placebo treatment can significantly influence subjective symptoms. However, it is widely believed that response to placebo requires concealment or deception. We tested whether open-label placebo (non-deceptive and non-concealed administration) is superior to a no-treatment control with matched patient-provider interactions in the treatment of irritable bowel syndrome (IBS). METHODS: Two-group, randomized, controlled three week trial (August 2009-April 2010) conducted at a single academic center, involving 80 primarily female (70%) patients, mean age 47 ± 18 with IBS diagnosed by Rome III criteria and with a score ≥ 150 on the IBS Symptom Severity Scale (IBS-SSS). Patients were randomized to either open-label placebo pills presented as "placebo pills made of an inert substance, like sugar pills, that have been shown in clinical studies to produce significant improvement in IBS symptoms through mind-body self-healing processes" or no-treatment controls with the same quality of interaction with providers. The primary outcome was IBS Global Improvement Scale (IBS-GIS). Secondary measures were IBS Symptom Severity Scale (IBS-SSS), IBS Adequate Relief (IBS-AR) and IBS Quality of Life (IBS-QoL). FINDINGS: Open-label placebo produced significantly higher mean (±SD) global improvement scores (IBS-GIS) at both 11-day midpoint (5.2 ± 1.0 vs. 4.0 ± 1.1, p<.001) and at 21-day endpoint (5.0 ± 1.5 vs. 3.9 ± 1.3, p = .002). Significant results were also observed at both time points for reduced symptom severity (IBS-SSS, p = .008 and p = .03) and adequate relief (IBS-AR, p = .02 and p = .03); and a trend favoring open-label placebo was observed for quality of life (IBS-QoL) at the 21-day endpoint (p = .08). CONCLUSION: Placebos administered without deception may be an effective treatment for IBS. Further research is warranted in IBS, and perhaps other conditions, to elucidate whether physicians can benefit patients using placebos consistent with informed consent. TRIAL REGISTRATION: ClinicalTrials.gov NCT01010191.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The number-needed-to-treat was 11 which should be compared with 4 for ‘placebo without deception,259 7 for alosetron,260 8 for linaclotide261 and 14 for tegaserod.262”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [259]
The cited source says what the claim attributes to it.
In the citing paper
“Several trials of psychological treatments for IBS have failed to show differential effects on symptoms when using attention control conditions [32,62-64], and a recent study showed that IBS patients even respond to open-label placebo [65].”
The cited source says what the claim attributes to it.
In the citing paper
“Kaptchuk and colleagues showed that an open label inactive placebo pill produced better outcomes in IBS patients compared to no treatment13.”
From Is ginger effective for the treatment of irritable bowel syndrome? A double blind randomized controlled pilot trial (2014) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Discovery of Grounded Theory; Strategies for Qualitative Research
Glaser, B. G., Strauss, A. L., & Strutzel, E. (1968) · Nursing Research · doi:10.1097/00006199-196807000-00014 · Cited by 39,449
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Collecting and Interpreting Qualitative Materials
Denzin, N. K., & Lincoln, Y. S. (2012) · Cited by 6,094
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440 · cited 1×
“Participants were adults ($18 years old) meeting the Rome III criteria for IBS [17] with a score of $150 on the IBS Symptom Severity Scale (IBS-SSS).”
MethodFRANCIS, C. Y., MORRIS, J., & WHORWELL, P. J. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.142318000.x · Cited by 1,708 · cited 3×
“[18] The open-label group improved by 92 points on this measure; in addition, the improvement shown by the openlabel placebo group exceeded that shown by the no-treatment group by 46 points.”
MethodInfluentialIs the Placebo Powerless?: An Analysis of Clinical Trials Comparing Placebo with No Treatment
Hróbjartsson, A., & Gøtzsche, P. C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105243442106 · Cited by 1,503
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384 · cited 1×
“[7,8] It is a chronic functional gastrointestinal disorder characterized by abdominal pain and discomfort associated with altered bowel habits.”
BackgroundBiological, clinical, and ethical advances of placebo effects
Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61706-2 · Cited by 1,272
Self-citation
Research works printed but not linked: 1
- Vanner SJ Depew WT Paterson WG 2004 Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome and functional dyspepsia. Gut 53 666 72 · DOI · Paper page
Cited by
Items 201–300 of 897
Placebo Effects of Open-label Verbal Suggestions on Itch
Meeuwis, S. H., van Middendorp, H., Veldhuijzen, D. S., van Laarhoven, A. I. M., Houwer, J. D., Lavrijsen, A. P. M., & Evers, A. W. M. (2018) · Acta Dermato Venereologica · doi:10.2340/00015555-2823 · Cited by 35
“Previous studies, however, have always combined openlabel placebo pill administration with the rationale that explained that “the placebo effect can be powerful” and that “the body may respond automatically to placebo treatment” (21, 22, 28).”
BackgroundResultInfluentialPlacebo Effects in Idiopathic and Neuropathic Pain Conditions
Vase, L., Petersen, G. L., & Lund, K. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44519-8_7 · Cited by 34
Kotsis, V., Benson, S., Bingel, U., Forsting, M., Schedlowski, M., Gizewski, E. R., & Elsenbruch, S. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01968.x · Cited by 37
Who responds to placebos? Considering the “placebo personality” via a transactional model
Darragh, M., Booth, R. J., & Consedine, N. S. (2014) · Psychology Health & Medicine · doi:10.1080/13548506.2014.936885 · Cited by 39
“, 2009), even when patients are told they are receiving a placebo treatment (Kaptchuk et al., 2010).”
BackgroundCan a Brief Relaxation Exercise Modulate Placebo or Nocebo Effects in a Visceral Pain Model?
Elsenbruch, S., Roderigo, T., Enck, P., & Benson, S. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00144 · Cited by 37
“This is underscored by trials supporting the efficacy of placebo interventions in patients with chronic low back pain (6, 7) and chronic visceral pain (8, 9).”
Jiwa, M., Millett, S., Meng, X., & Hewitt, V. (2012) · Journal of Medical Internet Research · doi:10.2196/jmir.1986 · Cited by 32
Placebo analgesia: cognitive influences on therapeutic outcome
Watson, A., Power, A., Brown, C. A., El‐Deredy, W., & Jones, A. K. P. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3783 · Cited by 40
“Another example of the nondeceptive use of placebo was provided by Kaptchuk and colleagues [3].”
Rewarded placebo analgesia: A new mechanism of placebo effects based on operant conditioning
Adamczyk, W. M., Wiercioch‐Kuzianik, K., Bajcar, E. A., & Bąbel, P. (2019) · European Journal of Pain · doi:10.1002/ejp.1360 · Cited by 33
“This idea is tempting, especially now, when clinical applications for the use of placebo treatments have been developed (Klinger, Colloca, Bingel, & Flor, 2014), and even when open‐label placebos are encountered (Ballou et al., 2017; Carvalho et al., 2016; Kaptchuk et al., 2010; Kelley, Kaptchuk, Cusin, Lipkin, & Fava…”
BackgroundEsch, T. (2020) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-020-03133-8 · Cited by 40
Bishop, F. L., Adams, A. E. M., Kaptchuk, T. J., & Lewith, G. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039661 · Cited by 36
“Trials in conditions that are known to have strong placebo responses (e.g. IBS [3,4], musculoskeletal pain [5,6], depression [7,8]) might emphasise the possible effects and wellestablished mechanisms of placebo, while trials in conditions that are less responsive to placebos might emphasise the processes that can lead…”
BackgroundInfluentialSelf-citationPlacebo and nocebo effects: from observation to harnessing and clinical application
Tu, Y., Zhang, L., & Kong, J. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02293-2 · Cited by 39
“Randomized clinical trials of open-label placebos in different conditions, including patients with irritable bowel syndrome [133], cLBP [134], cancer-related fatigue [135], and episodic migraine [136], have demonstrated the therapeutic efficacy of open-label placebos.”
BackgroundBeshai, S., Mishra, S., Mishra, S., & Carleton, R. N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189666 · Cited by 43
Pain Response to Open Label Placebo in Induced Acute Pain in Healthy Adult Males
Schneider, T., Luethi, J., Mauermann, E., Bandschapp, O., & Ruppen, W. (2019) · Anesthesiology · doi:10.1097/aln.0000000000003076 · Cited by 36
Halland, M., & Talley, N. J. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.207 · Cited by 40
Ashar, Y. K., Sun, M. M. C., Knight, K., Flood, T. F., Anderson, Z. G., Kaptchuk, T. J., & Wager, T. D. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.32427 · Cited by 34
Self-citationThe Influence of Expectation on Nondeceptive Placebo and Nocebo Effects
Wei, H., Zhou, L., Zhang, H., Chen, J., Lu, X., & Hu, L. (2018) · Pain Research and Management · doi:10.1155/2018/8459429 · Cited by 35
“It has been demonstrated that open-label placebo accompanied with positive verbal suggestion and/or a context of supportive patientpractitioner relationship alters pain perception in patients with irritable bowel syndrome (IBS) or chronic low back pain [10, 11].”
BackgroundEffects of Open- and Closed-Label Nocebo and Placebo Suggestions on Itch and Itch Expectations
Meeuwis, S. H., van Middendorp, H., van Laarhoven, A. I. M., Veldhuijzen, D. S., Lavrijsen, A. P. M., & Evers, A. W. M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00436 · Cited by 34
The potential role of illness expectations in the progression of medical diseases
Pagnini, F. (2019) · BMC Psychology · doi:10.1186/s40359-019-0346-4 · Cited by 30
“Of course, the placebo response is not always obtained through a lack of, or limited information (see, for example, the emerging openlabel placebo model [4, 5]).”
BackgroundOpen-Label Placebo Treatment: Outcome Expectations and General Acceptance in the Lay Population
Haas, J. W., Rief, W., & Doering, B. K. (2020) · International Journal of Behavioral Medicine · doi:10.1007/s12529-020-09933-1 · Cited by 35
Is acupuncture a placebo therapy?
Zheng, Y.-C., Yuan, T., & Liu, T. (2014) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2014.05.005 · Cited by 34
The Integrality of Situated Caring in Nursing and the Environment
Jarrin, O. F. (2012) · Advances in Nursing Science · doi:10.1097/ans.0b013e3182433b89 · Cited by 35
Ashar, Y. K., Lumley, M. A., Perlis, R. H., Liston, C. M., Gunning, F. M., & Wager, T. D. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.33846 · Cited by 34
Transcranial magnetic stimulation as a treatment for functional (psychogenic) upper limb weakness
McWhirter, L., Ludwig, L., Carson, A. J., McIntosh, R. D., & Stone, J. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.08.010 · Cited by 29
Neural underpinnings of open-label placebo effects in emotional distress
Schaefer, M., Kühnel, A., Schweitzer, F. M., Enge, S., & Gärtner, M. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01501-3 · Cited by 37
Kisaalita, N. R., Staud, R. M., Hurley, R. W., & Robinson, M. (2014) · Pain · doi:10.1016/j.pain.2014.09.029 · Cited by 33
“Additionally, an explicit, open-label placebo RCT for IBS patients produced large and clinically meaningful reductions in IBS symptom severity [19].”
BackgroundPlasma Hormones Facilitated the Hypermotility of the Colon in a Chronic Stress Rat Model
Liang, C., Luo, H., Liu, Y., Cao, J., & Xia, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031774 · Cited by 33
Context-dependency in valuation
Tymula, A. A., & Plaßmann, H. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2016.06.015 · Cited by 34
“Current Opinion in Neurobiology 2016, 40:59–65 they are receiving a placebo pill, they still exhibit a placebo hypoanalgesic response [54], and in some studies the magnitude of placebo effects increased over time [55,56].”
BackgroundLocher, C., Nascimento, A. F., Kossowsky, J., Meyer, A. H., & Gaab, J. (2018) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2018.11.009 · Cited by 36
The Effects of Manipulating Verbal Suggestions on Physical Performance
Carlino, E., Benedetti, F., & Pollo, A. (2014) · Zeitschrift für Psychologie · doi:10.1027/2151-2604/a000178 · Cited by 30
Burbank, F. H., Buchfuhrer, M. J., Kopjar, B., & Segawa, C. (2013) · Journal of Parkinsonism and Restless Legs Syndrome · doi:10.2147/jprls.s40354 · Cited by 27
“By contrast, a similar open-label heat-source comparison(41) may not have demonstrated the effect of leg heating, as open-label placebo treatment has recently been shown to be effective.(42)”
Organ-specificity of placebo effects on blood pressure
Meißner, K., & Ziep, D. (2011) · Autonomic Neuroscience · doi:10.1016/j.autneu.2011.06.006 · Cited by 33
Bishop, F. L., Howick, J., Heneghan, C. J., Stevens, S., Hobbs, R. F., & Lewith, G. T. (2014) · Family Practice · doi:10.1093/fampra/cmu016 · Cited by 29
“Recent evidence challenges this, suggesting that deception may not always be necessary to elicit beneficial placebo effects in clinical populations (18).”
BackgroundMbizvo, G. K., Nevitt, S. J., Nurmikko, T. J., & Göebel, A. (2014) · Journal of Pain · doi:10.1016/j.jpain.2014.11.008 · Cited by 29
“Understanding the size of placebo response also helps determine whether a placebo could be used to achieve therapeutic effects.(35) Finally, placebo response sizes may also convey information about disease-associated neurobiological processes.”
BackgroundNocebo Effects and Experimental Models in Visceral Pain
Elsenbruch, S., & Labrenz, F. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.01.010 · Cited by 30
Complementary and alternative drug therapy versus science-oriented medicine
Anlauf, M., Hein, L., Hense, H., Köbberling, J., Lasek, R., Leidl, R., & Schöne-Seifert, B. (2015) · PubMed Central · doi:10.3205/000209 · Cited by 42
“A recommendation to “openly” administer placebos in therapeutic practice cannot however (yet) be derived from these studies, which are partially fraught with methodical shortcomings [159], [160] or present results of a pilot study in a singular indication which are to be confirmed [158].”
BackgroundResultInfluentialSelf‐Fulfilling Prophesies, Placebo Effects, and the Social–Psychological Creation of Reality
Crum, A. J., & Phillips, D. J. (2015) · Wiley eBooks · doi:10.1002/9781118900772.etrds0296 · Cited by 37
“…are only just beginning to explore ways to tap into and deliberately (i.e., nondeceptively) utilize the placebo effect in clinical settings (Kaptchuk et al., 2010) and metabolic and nutritional scientists continue to offer dieting solutions that ignore the role of mindset in metabolic…”
BackgroundHow Positive and Negative Expectations Shape the Experience of Visceral Pain
Elsenbruch, S. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44519-8_6 · Cited by 27
“(Kaptchuk et al. 2010), have impressively demonstrated the putative clinical potential of placebo treatment in IBS.”
BackgroundLatent Inhibition Reduces Nocebo Nausea, Even Without Deception
Quinn, V. F., Livesey, E. J., & Colagiuri, B. (2017) · Annals of Behavioral Medicine · doi:10.1007/s12160-016-9867-8 · Cited by 26
Modulation of the Motor System by Placebo and Nocebo Effects
Fiorio, M. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.07.012 · Cited by 28
Hahn, A., Göhler, A. C., Hermann, C., & Winkler, A. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.02.043 · Cited by 28
Rexwinkel, R., Vlieger, A. M., Saps, M., Tabbers, M. M., & Benninga, M. A. (2022) · European Journal of Pediatrics · doi:10.1007/s00431-022-04459-y · Cited by 34
“Similar trials in adults with IBS have shown promising results [150, 151].”
ResultYennurajalingam, S., Azhar, A., Lu, Z., Rodriguez, A. J., Arechiga, A. B., Guerra-Sanchez, M., Stanton, P. A., Andersen, C. R., Urbauer, D. L., & Bruera, E. D. (2022) · The Oncologist · doi:10.1093/oncolo/oyac184 · Cited by 26
Palmer, A. M., & Brandon, T. H. (2018) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000303 · Cited by 117
“Moreover, in other domains, placebo medications have retained their efficacy even after their content has been revealed to patients (i.e., open-label placebo; Kaptchuk et al., 2010).”
A comparison of open-label and deceptive placebo analgesia in a healthy sample
Disley, N., Kola, S., & Retzler, C. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110298 · Cited by 28
Placebo From an Enactive Perspective
Arandia-Romero, I., & Paolo, E. A. D. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.660118 · Cited by 29
“For instance, a relatively recent experimental paradigm that can be explained in terms of the dynamics of reflective and pre-reflective processes is that of open-label placebos (OLP; Kaptchuk et al., 2010), as we shall discuss in the next section.”
BackgroundTranslating knowledge on placebo and nocebo effects into clinical practice
Caliskan, E. B., Bingel, U., & Kunkel, A. (2024) · PAIN Reports · doi:10.1097/pr9.0000000000001142 · Cited by 35
“…evidence for the beneficial effects of OLP treatments on experimental, acute, and various chronic pain disorders 80 (such as migraine, 46 chronic back pain, 23,51 and irritable bowel syndrome 47 ), as well as on other subjective complaints, such as cancer-related fatigue 83 or depressive symptoms.”
BackgroundThe placebo in practice: how to use it in clinical routine
Carlino, E., Pollo, A., & Benedetti, F. (2012) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e32835269c1 · Cited by 28
Elite athletes' attitudes towards the use of placebo‐induced performance enhancement in sports
Bérdi, M., Köteles, F. G., Hevesi, K., Bárdos, G., & Szabó, A. (2014) · European Journal of Sport Science · doi:10.1080/17461391.2014.955126 · Cited by 27
“Further, new research results are emerging in which placebo intervention may be adopted without deception (Kaptchuk et al., 2010).”
BackgroundAn Analysis of the Basic Processes of Formation and Change of Placebo Expectations
Geers, A. L., Briñol, P., & Petty, R. E. (2018) · Review of General Psychology · doi:10.1037/gpr0000171 · Cited by 31
“In several open-label experiments, participants have improved from placebo treatments even when they were made aware that the treatments were inert (e.g., Charlesworth et al., 2017; Kaptchuk et al., 2010).”
Kirsch, I. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0410 · Cited by 27
Self-citation‘Placebos’ and the logic of placebo comparison
Turner, A. J. (2011) · Biology & Philosophy · doi:10.1007/s10539-011-9289-8 · Cited by 27
Hoffmann, V. S., Lanz, M., Mackert, J., Müller, T. D., Tschöp, M. H., & Meißner, K. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00706 · Cited by 28
What are the Key Characteristics of a ‘Good’ Psychotherapy? Calling for Ethical Patient Involvement
Gerger, H., Nascimento, A. F., Locher, C., Gaab, J., & Trachsel, M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00406 · Cited by 50
Assessing the Impact of Expectations in Cognitive Training and Beyond
Denkinger, S., Spano, L. P., Bingel, U., Witt, C. M., Bavelier, D., & Green, C. S. (2021) · Journal of Cognitive Enhancement · doi:10.1007/s41465-021-00206-7 · Cited by 27
“…to participants that “the placebo effect can be powerful, [that] the body automatically can respond to taking placebo pills, [that] a positive attitude can be helpful but is not necessary and taking the pills faithfully…is critical” (for full citation of instructions, see Kaptchuk et al. 2010).”
BackgroundImaginary pills and open-label placebos can reduce test anxiety by means of placebo mechanisms
Buergler, S., Sezer, D., Bagge, N., Kirsch, I., Locher, C., Carvalho, C., & Gaab, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-29624-7 · Cited by 27
Self-citationMahady, A., Takac, M., & Foe, A. D. (2023) · Consciousness and Cognition · doi:10.1016/j.concog.2023.103477 · Cited by 32
What It Takes to Defend Deceptive Placebo Use
Barnhill, A. (2011) · Kennedy Institute of Ethics journal · doi:10.1353/ken.2011.0015 · Cited by 24
An enactive account of placebo effects
Ongaro, G., & Ward, D. (2017) · Biology & Philosophy · doi:10.1007/s10539-017-9572-4 · Cited by 33
van Middendorp, H., Kox, M., Pickkers, P., & Evers, A. W. M. (2015) · Clinical Rheumatology · doi:10.1007/s10067-015-3009-8 · Cited by 25
Placebo effects in obesity research
Fontaine, K. R., Williams, M. S., Hoenemeyer, T. W., Kaptchuk, T. J., & Dutton, G. R. (2016) · Obesity · doi:10.1002/oby.21456 · Cited by 26
“Collectively, PRFs may promote improved outcomes even when participants do not receive a bioactive treatment and regardless of whether they are aware of this (3-5).”
Self-citationRole of placebo effects in pain and neuropsychiatric disorders
Belcher, A. M., Ferré, S., Martinez, P. E., & Colloca, L. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.003 · Cited by 29
“, 2016), irritable bowel syndrome (Kaptchuk et al., 2010), sleep disorders (Perlis et al.”
BackgroundLinnman, C., Catana, C., Petkov, M. P., Chonde, D. B., Becerra, L. R., Hooker, J. M., & Borsook, D. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.11.011 · Cited by 25
“full disclosure, may still be effective (Kaptchuk et al., 2010), prior studies indicate that placebo effects are stronger if subjects are deceived to believe they get an active drug (Kirsch and Weixel, 1988), or if the probability of receiving and active drug is higher (R.”
Galindo, M. N., Navarro, J. F., & Cavas, M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00849 · Cited by 35
Kleine‐Borgmann, J., Dietz, T.-N., Schmidt, K., & Bingel, U. (2022) · Pain · doi:10.1097/j.pain.0000000000002752 · Cited by 24
Working with patients’ treatment expectations – what we can learn from homeopathy
Wilhelm, M., Hermann, C., Rief, W., Schedlowski, M., Bingel, U., & Winkler, A. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1398865 · Cited by 27
Adverse events appear to unblind clinical trials in irritable bowel syndrome
Shah, E., Triantafyllou, K., Hana, A. A., & Pimentel, M. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12289 · Cited by 23
Ford, A. C., Luthra, P., Hanauer, S. B., Travis, S. P. L., Harris, M. S., & Reinisch, W. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.08.038 · Cited by 23
Goldenholz, D. M., Strashny, A., Cook, M. J., Moss, R., & Theodore, W. H. (2017) · Seizure · doi:10.1016/j.seizure.2017.10.016 · Cited by 25
“A prospective randomized clinical trial with seizure reduction as an outcome measure, with placebo and no intervention, would offer the best possible evidence, as has been done in several other diseases [30,31].”
BackgroundPsychotherapy and Placebos: Manifesto for Conceptual Clarity
Blease, C. R. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00379 · Cited by 23
Hardman, D. I., Geraghty, A. W. A., Lewith, G. T., Lown, M. T., Viecelli, C., & Bishop, F. L. (2018) · Health An Interdisciplinary Journal for the Social Study of Health Illness and Medicine · doi:10.1177/1363459318800169 · Cited by 25
Mind Your Expectations: Exploring the Roles of Suggestion and Intention in Mindfulness Training
Farb, N. A. S. (2012) · Cited by 33
Current Concepts of Pain Pathways: A Brief Review of Anatomy, Physiology, and Medical Imaging
Gonzalez-Hermosillo, D.-C., González-Hermosillo, L.-M., Villaseñor-Almaraz, M., Herrera, D. B., Moreno‐Jiménez, S., Corona-Cedillo, R., Velasco‐Campos, F., Carrillo-Ruiz, J. D., & Roldán-Valadéz, E. (2023) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/1573405620666230519144112 · Cited by 34
Ravines and Sugar Pills: Defending Deceptive Placebo Use
Pugh, J. (2014) · The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine · doi:10.1093/jmp/jhu045 · Cited by 22
“As such, the action was not under the direction of my will (Killmister, 2013, 521).”
BackgroundDong, Y., Berens, S., Eich, W., Schaefert, R., & Tesarz, J. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019453 · Cited by 28
“Measurement of Ibs symptom severity Patients rated the severity of their IBS symptoms by completing the IBS severity score system (IBS-SSS).(15) The IBS-SSS has a maximum score of 500 and comprises five items: frequency and intensity of abdominal pain, severity of abdominal distension, dissatisfaction with bowel habit…”
MethodDeceptive but not open label placebos attenuate motion-induced nausea
Barnes, K., Yu, A., Josupeit, J., & Colagiuri, B. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2019.109808 · Cited by 25
Antonelli, M., & Donelli, D. (2018) · Health & Social Care in the Community · doi:10.1111/hsc.12681 · Cited by 26
Providing open-label placebos remotely—A randomized controlled trial in allergic rhinitis
Κube, T., Hofmann, V. E., Glombiewski, J. A., & Kirsch, I. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248367 · Cited by 21
“However, research has demonstrated that placebos being honestly prescribed to patients (so called “open-label placebos” = OLPs) can lead to symptom reduction in irritable bowel syndrome [5], chronic back pain [6, 7], migraine [8], cancer-related fatigue [9, 10], attention-deficit hyperactivity disorder [11, 12], depre…”
BackgroundSelf-citationTranscranial magnetic stimulation and sedation as treatment for functional neurologic disorders
Nicholson, T. R., & Voon, V. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-801772-2.00050-3 · Cited by 24
“This counterintuitive phenomenon has also been found more generally for placebos in that it works, even when clearly labeled as such (Kaptchuk et al., 2010), and it is perhaps relevant that this studywas in irritable-bowel syndrome – a functional gastrointestinal disorder.”
Darragh, M., Yow, B., Kieser, A., Booth, R. J., Kydd, R. R., & Consedine, N. S. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415621390 · Cited by 21
“…improvements in IBS symptomology after participants were told they had been given an inert substance, but that the treatment has ‘been shown in rigorous clinical testing to produce significant improvement in IBS symptoms through mind-body self-healing processes’ (Kaptchuk et al., 2010: 2).”
BackgroundFriesen, P., & Dionne, É. (2022) · Science & Technology Studies · doi:10.23987/sts.110291 · Cited by 22
“Some of the early experiments involving open-label placebos have been remarkably successful in generating symptom relief in research participants who suffer from migraines, chronic low back pain, and irritable bowel syndrome, as well as children with diagnoses of ADHD (Kaptchuk et al., 2010; Kam-Hansen et al., 2014; C…”
BackgroundFendel, J. C., Tiersch, C., Sölder, P., Gaab, J., & Schmidt, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-14895-z · Cited by 27
“Most OLP interventions are accompanied by a standardized rationale originally developed by Kaptchuk et al. 12 , which typically includes the following four suggestive elements: (1) the placebo effect is powerful, (2) the body is automatically responding to placebos, (3) a positive attitude towards palcebos is not nece…”
InfluentialSondermann, W., Jockenhöfer, F., Dissemond, J., Pfaar, O., Bingel, U., & Schedlowski, M. (2021) · Dermatology · doi:10.1159/000513445 · Cited by 24
Ortega, Á., Salazar, J. J., Galbán, N., Rojas, M., Ariza, D. V., Chávez-Castillo, M., Nava, M., Riaño-Garzón, M., Díaz-Camargo, E. A., Medina, Ó., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084196 · Cited by 23
“This has been shown in an experimental study performed by Vase et al. in 2005 in a sample of 26 female patients with irritable bowel syndrome (IBS).”
BackgroundBelieving, Remembering, and Imagining: The Roots and Fruits of Meanings Made and Remade
Paloutzian, R. F., & Mukai, K. J. (2017) · New approaches to the scientific study of religion · doi:10.1007/978-3-319-50924-2_3 · Cited by 21
Medicine is Patriarchal, But Alternative Medicine is Not the Answer
Shahvisi, A. (2018) · Journal of Bioethical Inquiry · doi:10.1007/s11673-018-9890-5 · Cited by 35
More than consent for ethical open-label placebo research
Sullivan, L. S. (2020) · Journal of Medical Ethics · doi:10.1136/medethics-2019-105893 · Cited by 25
Olliges, E., Stroppe, S., Haile, A., Reiß, F., Malhis, M., Funke, S. A., & Meißner, K. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.853497 · Cited by 22
Belcher, A. M., Cole, T. O., Massey, E. C., Billing, A. S., Wagner, M. A., Wooten, W., Epstein, D. H., Hoag, S. W., Wickwire, E. M., Greenblatt, A. D., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.7099 · Cited by 20
Self-citationSchaefer, M., & Enck, P. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031339 · Cited by 26
Belcher, A. M., Cole, T. O., Greenblatt, A. D., Hoag, S. W., Epstein, D. H., Wagner, M. A., Billing, A. S., Massey, E. C., Hamilton, K. R., Kozak, Z., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026604 · Cited by 22
Self-citationMeeuwis, S. H., van Middendorp, H., van Laarhoven, A. I. M., van Leijenhorst, C., Pacheco‐López, G., Lavrijsen, A. P. M., Veldhuijzen, D. S., & Evers, A. W. M. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.03.025 · Cited by 24
“, 2018), research from various other fields further supports the notion that placebo effects can be elicited even when it is known that an inert substance is given (Carvalho et al., 2016; Charlesworth et al., 2017; Kaptchuk et al., 2010; Kelley et al., 2012; Sandler and Bodfish, 2008).”
BackgroundBallou, S., Haas, J. W., Iturrino, J., Nee, J. W., Kirsch, I., Rangan, V., Cheng, V., Lembo, A. J., Kaptchuk, T. J., & Kelley, J. M. (2022) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001078 · Cited by 22
“In an initial study (8), we demonstrated that prescribing placebo “openlabel” (i.”
BackgroundSelf-citationEnactive and simondonian reflections on mental disorders
García, E., & Arandia-Romero, I. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.938105 · Cited by 23
“2767), explaining scientific evidence that supports placebo effects (Kaptchuk et al., 2010) or emphasizing the importance of following the instructions to take the placebo pills as in usual treatments (Hoenemeyer et al.”
BackgroundGreco, C. M., Glick, R. M., Morone, N. E., & Schneider, M. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/613797 · Cited by 23
Acupuncture—help, harm, or placebo?
Meldrum, D. R., Fisher, A. R., Butts, S. F., Su, H.-C. I., & Sammel, M. D. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.12.046 · Cited by 20
Empirical Support for a Self-help Treatment for IBS
Hunt, M. G., Ertel, E., Coello, J. A., & Rodriguez, L. (2014) · Cognitive Therapy and Research · doi:10.1007/s10608-014-9647-3 · Cited by 23
“IBS is known to have a fairly large placebo response rate (e.g. Kaptchuk et al. 2010), so using a waitlist control presumably magnified the group differences.”
BackgroundKnowledge and Belief in Placebo Effect
Chiffi, D., & Zanotti, R. (2016) · The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine · doi:10.1093/jmp/jhw033 · Cited by 19
Deceptive and non-deceptive placebos to reduce sadness: A five-armed experimental study
Friehs, T., Rief, W., Glombiewski, J. A., Haas, J. W., & Κube, T. (2022) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2022.100349 · Cited by 22
Marchant, J. (2016) · Nature · doi:10.1038/535s14a · Cited by 22
Brain Predictors of Individual Differences in Placebo Responding
Koban, L., Ruzic, L. L., & Wager, T. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397928-5.00010-6 · Cited by 26
Metadata
- Authors
- Kaptchuk, T. J., Friedlander, E., Kelley, J. M., Sanchez, M. N., Kokkotou, E., Singer, J. P., Kowalczykowski, M., Miller, F. G., Kirsch, I., & Lembo, A. J.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- National Institutes of Health (US)
- University of Hull (GB)
- Corresponding author
- Kaptchuk, Ted J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-12-22
- Volume
- 5
- Issue
- 12
- Pages
- e15591
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3008733
- OpenAlex
- W2105330971
- Semantic Scholar
- 3d8aac4fba0e556c2d0898ad83cd3df11576e90c
- Cited by
- 900
- References
- 43
- Citations by year
- 2026: 28 · 2025: 44 · 2024: 48 · 2023: 56 · 2022: 55 · 2021: 67 · 2020: 72 · 2019: 55 · 2018: 97 · 2017: 48 · 2016: 55 · 2015: 55 · 2014: 65 · 2013: 48 · 2012: 58
- FWCI
- 29.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- U.S. Department of Health and Human Services
- Bernard Osher Foundation
- National Institutes of Health (5r01at000402-04)
- Japan Society for the Promotion of Science (13J11021)
- National Center for Complementary and Alternative Medicine
- National Center for Complementary and Integrative Health (R01AT004662, K24AT004095, R01 AT00402-01)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Complementary and alternative medicine › Acupuncture Treatment Research Studies
- Keywords
- irritable bowel syndrome, placebo effect, open-label placebo, symptom severity, quality of life, patient-provider interaction, informed consent
- MeSH terms
- Adult, Female, Humans, Deception, Male, Middle Aged, Placebos, Time Factors, Treatment Outcome, Patient Satisfaction, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

